Hagit Eldar-Finkelman

Prof. Hagit Eldar-Finkelman - Tel Aviv University - (August 2021) Hagit Eldar-Finkelman () is an Israeli scientist and a principal investigator of an active research laboratory at the Sackler School of Medicine at Tel Aviv University. Eldar-Finkelman’s research is focused on the signal transduction field and drug development targeting protein kinases. She is well known for her pioneering work on the functions of GSK-3 and its contribution to diabetes and other pathogenies, including depressive behavior, Alzheimer’s diseases, and Huntington’s diseases. Novel findings also include the unique evolution of GSK-3 isozymes. Eldar-Finkelman is a leading figure in developing novel substrate competitive inhibitors (SCIs) for GSK-3 with significant benefits as drug candidates. Provided by Wikipedia
Showing 1 - 1 results of 1 for search 'Hagit Eldar-Finkelman', query time: 0.01s Refine Results
  1. 1
    Small molecule modulation of p75NTR engages the autophagy-lysosomal pathway and reduces huntingtin aggregates in cellular and mouse models of Huntington's disease

    Small molecule modulation of p75NTR engages the autophagy-lysosomal pathway and reduces huntingtin aggregates in cellular and mouse models of Huntington's disease by Danielle A. Simmons, Namitha Alexander, Gloria Cao, Ido Rippin, Yarine Lugassy, Hagit Eldar-Finkelman, Frank M. Longo

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: